1 - 12 toradh á dtaispeáint as 12 toradh san iomlán ar an gcuardach 'John DaSilva (15051035)', am iarratais: 0.01s Beachtaigh na torthaí
  1. 1
    Supplementary Figure 8 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC

    Supplementary Figure 8 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant... de réir Seung Yeon Oh (15051017)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Supplementary Table 2 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC

    Supplementary Table 2 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant N... de réir Seung Yeon Oh (15051017)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Supplementary Figure 9 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC

    Supplementary Figure 9 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant... de réir Seung Yeon Oh (15051017)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Supplementary Figure 2 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC

    Supplementary Figure 2 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant... de réir Seung Yeon Oh (15051017)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Supplementary Figure 10 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC

    Supplementary Figure 10 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant... de réir Seung Yeon Oh (15051017)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Supplementary Figure 5 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC

    Supplementary Figure 5 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant... de réir Seung Yeon Oh (15051017)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Supplementary Figure 3 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC

    Supplementary Figure 3 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant... de réir Seung Yeon Oh (15051017)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Supplementary Table 1 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC

    Supplementary Table 1 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant N... de réir Seung Yeon Oh (15051017)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Supplementary Figure 4 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC

    Supplementary Figure 4 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant... de réir Seung Yeon Oh (15051017)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Supplementary Figure 1 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC

    Supplementary Figure 1 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant... de réir Seung Yeon Oh (15051017)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Supplementary Figure 7 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC

    Supplementary Figure 7 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant... de réir Seung Yeon Oh (15051017)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Supplementary Figure 6 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC

    Supplementary Figure 6 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant... de réir Seung Yeon Oh (15051017)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe:
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: